3% of medicines are of poor quality: Survey

The survey found that out of the 47,012 samples tested, 13 samples were spurious and 1,850 samples were not of standard quality (NSQ).

GN Bureau | February 25, 2017


#Health ministry   #medicines   #poor quality   #spurious   #India news  

 More than three percent of medicines in India are ‘Not of Standard Quality’ (NSQ) and 0.0245 percent spurious, reveals a survey report on drugs quality by the ministry of health. 

The survey carried out by National Institute of Biologicals (NIB), Noida found that out of the 47,012 samples tested, 13 samples were spurious and 1,850 samples were NSQ.  
 
It is the largest ever scientifically designed and professionally executed drug survey undertaken in the world for determining the quality of drugs, a press statement released by the ministry said.
 
 
It included as many as 224 drug molecules belonging to 15 different therapeutic categories of the National List of Essential Medicines (NLEM) 2011. As part of this survey, 47,954 drug samples relating to 23 dosage forms were drawn from 654 districts of 36 states and union territories from the supply chains including retail outlets, government sources and from eight airports and sea ports.
 
All the samples were subjected to test and analysis in the central and state drug testing laboratories that have been accredited by National Accreditation Board for Testing and Calibration Laboratories (NABL).  A nationwide training in drugs survey methodology was imparted at 28 centres across the country to over 1800 Sample Drawing Officers (SDOs) and representatives of the Civil society / pharmacy council of India (PCI). 
 
They observed that the drugs samples are drawn in accordance with the sampling methodology and the highest degree of transparency and objectivity is maintained in the process to eliminate any bias.
 

 

Comments

 

Other News

In Maharashtra, what’s allowed, what’s not

Essential services allowed: 1) Hospitals, diagnostic centres, clinics, vaccinations, medical insurance offices, pharmacies, pharmaceutical companies, other medical and health services including supporting manufacturing and distribution units. This would also include dealers, transpo

Maharashtra goes under ‘Janata curfew’, restrictions from tonight

Striving to control the deadly second wave of Covid-19 infections, the Maharashtra government has imposed prohibition on the gathering of more than four people as well as night curfew from Wednesday till May 1. Starting 8 pm Wednesday, Section 144 of CrPC (prohibition on the gathering of mor

Govt launches e-marketplace for aqua farmers

Union Commerce and Industry Minister Piyush Goyal inaugurated e-SANTA, an electronic marketplace providing a platform to connect aqua farmers and buyers. It aims to enable the farmers to get a better price and the exporters to directly purchase quality products from the farmers

Central Mine Planning and Design Institute to use a drone for coalfield survey

Ministry of Civil Aviation (MoCA) and Directorate General of Civil Aviation (DGCA) have granted a conditional exemption to Central Mine Planning and Design Institute (CMPDI) for surveying in coalfield areas of Coal India Ltd. The drones will be deployed for the acquisition of d

Govt rolls out SARTHAQ for NEP 2020 implementation

In pursuance of the goals and objectives of the National Education Policy (NEP) 2020 and to assist States and UTs in this task, the Department of School Education and Literacy has developed an indicative and suggestive implementation plan for School Education called ‘Stud

NITI Aayog launches the version 2.0 of India Energy Dashboard

Dr Rajiv Kumar, Vice Chairman, NITI Aayog; Dr V K Saraswat, Member, NITI Aayog; Amitabh Kant, CEO, NITI Aayog; and Dr Rakesh Sarwal, Additional Secretary, NITI Aayog in the presence of Secretaries from Ministry of Coal, Ministry of Power, Ministry of Petroleum and Natural Gas,

Visionary talk with Prithviraj Chavan, On the need for vaccination & Maha Political volcano



Archives

Current Issue

Opinion

Facebook    Twitter    Google Plus    Linkedin    Subscribe Newsletter

Twitter